Publicidad
Caso clínico 31 de mayo de 2013

Estudio PET con 68Ga-Dotatate falso positivo causado por la presencia de un bazo accesorio

Referenciar Imprimir Descargar PDF

Referencias

  1. Carrasquillo JA, Chen CC. Molecular imaging of neuroendocrine tumors. Semin Oncol 2010; 37:662-79.
  2. Prasad V, Baum Rp. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging 2010; 54:61-7.
  3. Kurmann A, Michel JM, Stauffer E, Egger B. Intrapancreatic accessory spleen misdiagnosed as a nonsecreting endocrine tumor: case report and review of the literature. Case Rep Gastroenterol 2010; 4:210-14.
  4. Kroiss A, Putzer D, Decristoforo C, et al. 68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT. Eur J Nucl Med Mol Imaging. 2013; 40:514-23.
  5. Lebtahi R, Cadiot G, Marmuse JP, et al. False-positive somatostatin receptor scintigraphy due to an accessory spleen. J Nucl Med 1997; 38:1979-81.